Supplier
Franciscan Health Dyer & Hammond
Franciscan Health Dyer & Hammond was paid $4.52M by Medicaid between Jan 2018 and Dec 2024, across 44 billing codes. Its largest line is 41899, Unlisted procedure, dentoalveolar structures — 68% of everything it billed.
33Billing provider infoFRANCISCAN HEALTH DYER & HAMMOND
DYER, IN 46311
DYER, IN 46311
33aNPI1811077431assigned 10/17/2006
33bProvider typeDurable Medical Equipment & Medical Supplies
28Total paid$4.52M
24GClaims29,312
24DCodes billed44
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Durable Medical Equipment & Medical Supplies providers in Indiana
Rank by total paid#23 of 560
Median peer was paid$29.96
This provider vs. median150,994×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 1,489 | $34K | |
| 2019 | 1,729 | $93K | |
| 2020 | 1,433 | $71K | |
| 2021 | 1,595 | $238K | |
| 2022 | 5,935 | $1.44M | |
| 2023 | 8,910 | $1.39M | |
| 2024incomplete | 8,221 | $1.25M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 41899 | Unlisted procedure, dentoalveolar structures | 68% | 1,750 | 1,277 | $3.09M |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 7.6% | 3,243 | 2,735 | $346K |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 5.5% | 1,456 | 1,293 | $247K |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | 4.6% | 3,475 | 1,040 | $207K |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | 1.7% | 2,715 | 876 | $75K |
| 62323 | 1.6% | 84 | 70 | $74K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 1.6% | 1,369 | 496 | $70K |
| 64493 | 1.5% | 76 | 60 | $68K | |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 1.4% | 800 | 653 | $65K |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 1.2% | 340 | 288 | $55K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 1,797 | 521 | $43K |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | <1% | 1,618 | 587 | $41K |
32 more codes
| 99213 | Doctor's office visit, returning patient (routine) | <1% | 277 | $38K |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 198 | $14K |
| 64494 | <1% | 70 | $13K | |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 60 | $13K |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 417 | $10K |
| 80053 | Comprehensive metabolic panel | <1% | 1,167 | $9K |
| 36415 | Collection of venous blood by venipuncture | <1% | 2,646 | $9K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 1,329 | $7K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 100 | $7K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 122 | $6K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 107 | $4K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 27 | $3K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 13 | $2K |
| 86769 | <1% | 73 | $2K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 33 | $2K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 14 | $2K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 71 | $609.20 |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 14 | $297.50 |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | <1% | 81 | $229.12 |
| 80061 | Lipid panel | <1% | 13 | $129.90 |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 184 | $1.23 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 1,287 | $0.15 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 0% | 520 | $0.00 |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 0% | 359 | $0.00 |
| 77002 | 0% | 14 | $0.00 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 0% | 323 | $0.00 |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg | 0% | 58 | $0.00 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 0% | 390 | $0.00 |
| J1030 | Injection, methylprednisolone acetate, 40 mg | 0% | 77 | $0.00 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 0% | 518 | $0.00 |
| J1010 | Injection, methylprednisolone acetate, 1 mg | 0% | 12 | $0.00 |
| J1040 | Injection, methylprednisolone acetate, 80 mg | 0% | 15 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialGOLAN, JOSEPH (CFO - NORTHWEST INDIANA)
| Provider | Location | Paid |
|---|---|---|
| Franciscan Health Dyer & Hammond | Hammond, IN | $3.28M |
| Franciscan Health Munster | Munster, IN | $2.74M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.